News Roundup: FDA OKs Expanded Shingrix Indication; ThoughtSpot 2021 Kicks Off
Don’t waste time digging through articles to find the most up-to-date and important news. Drug Topics® has you covered with our weekly news roundup of the latest pharmacy-related news you should know before the weekend begins. Here’s a roundup of the latest news coverage from Drug Topics®.
FDA OKs Shingrix for Immunocompromised Adults 18 Years and Older
The FDA has expanded the indication for recombinant zoster vaccine, adjuvanted (Shingrix; GlaxoSmithKline) to include prevention of shingles in immunocompromised adults 18 years and older.
Good Neighbor Pharmacy’s 2021 State of the Union
This week, AmerisourceBergen and Good Neighbor Pharmacy (GNP) kicked off ThoughtSpot 2021, GNP’s annual conference and trade show.
Expert Interview: Part 1: Medicare Part B Provider Status for Pharmacists - Episode 1
In an interview with Drug Topics®, Ken Perez, MBA, vice president of Healthcare Policy and Government Affairs at Omnicell, explained the crucial points of Medicare Part B provider status for pharmacists, which would allow pharmacists in underserved communities to be reimbursed for certain primary care services that they already provide in commercially ensured populations.
Comparison of Blood Pressure Meds Points to Similar Benefit, but Different Adverse Effects
The American Heart Association (AHA) recently released new findings on 2 classes of blood pressure medications.
The AHA journal Hypertension published an analysis that looked at approximately 3 million patients taking a single high blood pressure medication for the first time. The analysis showed that 2 types of blood pressure-lowering medications—angiotensin-converting enzyme inhibitors and angiotensin receptor blockers—demonstrated similar benefits, but different adverse effects.
When Molecular Testing is Superior to Antigen Testing for Infectious Diseases
Providing people with the ability to test for viruses in their own homes empowers them to be proactive about their health while helping public health officials, policymakers, and researchers with information that could head off the next pandemic.
Fixed-Dose Combo Cream Treatment Approved for Acne Vulgaris
Sol-Gel Technologies has created a single-application acne treatment cream, combining 2 commonly used ingredients: tretinoin and benzoyl peroxide.
